PMID: 8437006Feb 1, 1993Paper

Correlation of interleukin-2 and soluble interleukin-2 receptor with clinical activity of multiple sclerosis

Journal of Neurology, Neurosurgery, and Psychiatry
M K Sharief, E J Thompson

Abstract

Concentrations of interleukin-2 (IL-2) and soluble IL-2 receptor (sIL-2R) in serum and CSF samples were measured in 63 patients with multiple sclerosis (MS) to evaluate their usefulness as markers of disease activity. CSF concentrations of IL-2 and sIL-2R were significantly higher in MS relapse compared with MS patients in remission or with control subjects. These concentrations correlated with the clinical score by which disease severity was assessed, with the number of relapses per year, and with the total disease duration. Furthermore, there was evidence of intrathecal release of IL-2 and sIL-2R in clinically active MS. The results extend the notion that an activated cellular immune state parallels the evolution of the pathological process in MS and suggest that measurement of IL-2 and sIL-2R concentrations may provide an objective marker of disease activity in patients with MS.

References

Sep 1, 1977·Scandinavian Journal of Clinical and Laboratory Investigation·G TibblingS Ohman
Feb 14, 1992·Journal of Immunological Methods·M K ShariefE J Thompson
Feb 1, 1991·Journal of the Neurological Sciences·P GalloA Sidén
Jun 22, 1989·The New England Journal of Medicine·D E GriffinA Vaisberg
Aug 1, 1989·Journal of Neurology, Neurosurgery, and Psychiatry·M K Sharief, E J Thompson
Dec 1, 1988·Journal of Neuroimmunology·M L CuznerM N Woodroofe
Dec 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·R P SanetoJ de Vellis
Nov 1, 1987·Annals of Neurology·B BoutinD L Nelson
May 21, 1988·British Medical Journal·M J Campbell, M J Gardner
Oct 13, 1988·The New England Journal of Medicine·S J GreenbergD L Nelson
Mar 1, 1983·Annals of Neurology·C M PoserW W Tourtellotte
Sep 1, 1982·Acta Neurologica Scandinavica·S PoserW Poser

❮ Previous
Next ❯

Citations

May 1, 1995·Annals of Neurology·S BansilC Rohowsky-Kochan
Feb 21, 2013·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Dimitrios Karussis
Apr 8, 1999·Clinical and Experimental Immunology·S InogésA Sánchez-Ibarrola
Jan 1, 1997·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·F SellebjergJ Frederiksen
Oct 17, 2001·The Journal of Clinical Investigation·S Markovic-PleseR Martin
Jan 1, 1995·Critical Reviews in Clinical Laboratory Sciences·R Martin, H F McFarland
Jun 1, 1997·Journal of Endodontics·C R RauschenbergerC J Cootauco
May 8, 2015·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Laurine Legroux, Nathalie Arbour
Feb 9, 2006·Journal of Immunological Methods·Nathalie ArbourJack P Antel
Jan 18, 2006·Journal of Endodontics·Masahiro YamasakiHiroshi Nakamura
Jul 3, 2010·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Majid ShahbaziSaleh Shahbazi
Jun 29, 2017·Multiple Sclerosis : Clinical and Laboratory Research·Ryotaro IkeguchiKazuo Kitagawa
Aug 27, 2010·Multiple Sclerosis : Clinical and Laboratory Research·Akiyuki UzawaSatoshi Kuwabara
Mar 4, 2005·Brain : a Journal of Neurology·Takaaki IshizuJun-ichi Kira
Nov 12, 2019·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Ali J Jahan-AbadAli Gorji
Jan 4, 2017·Molecular Pharmaceutics·Laura NorthrupCory Berkland

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved